Marc A Brouwer1, Freek W A Verheugt. Show Affiliations » 1. Heartcenter, Department of Cardiology, University Medical Center Nijmegen, The Netherlands.
Abstract
Entities: Disease
Mesh： See more » Administration, OralAgedAngiotensin-Converting Enzyme Inhibitors/administration & dosageAnticoagulants/administration & dosageAnticoagulants/adverse effectsAspirin/administration & dosageAspirin/adverse effectsClopidogrelControlled Clinical Trials as TopicDiabetes ComplicationsDose-Response Relationship, DrugDrug Administration ScheduleDrug Therapy, CombinationEchocardiographyElectrocardiographyFemaleHumansInternational Normalized RatioMaleMiddle AgedMyocardial Infarction/complicationsMyocardial Infarction/diagnosisMyocardial Infarction/drug therapyMyocardial Infarction/prevention & controlPatient Care PlanningRisk FactorsStroke/prevention & controlThrombosis/complicationsThrombosis/drug therapyThrombosis/prevention & controlTiclopidine/administration & dosageTiclopidine/analogs & derivativesWarfarin/administration & dosageWarfarin/adverse effects
Substances： See more » Angiotensin-Converting Enzyme InhibitorsAnticoagulantsWarfarinClopidogrelTiclopidineAspirin
Year: 2002 PMID： 11901033 DOI： 10.1161/hc1102.105594
Source DB: PubMed Journal: Circulation ISSN： 0009-7322 Impact factor: 29.690